Adverse Event Handling Timelines in Working Days under Order No. 540n

1. Key takeaways

Order No. 540n breaks the handling of an adverse event into six administrative milestones, all counted in working days: the expert organisation assesses causality within 3 working days → RZN notifies the manufacturer or authorised representative within 7 working days → the manufacturer submits initial information within 10 working days → full information is submitted within 30 working days → the expert organisation issues its opinion within 40 working days → RZN makes its decision within 10 working days. The two deadlines that apply to the manufacturer are calculated from the date on which RZN issues its notification, which means the clock that matters most to the company starts with a document the company does not control.

The arithmetic deserves attention in advance. From the moment of notification, the manufacturer has ten working days to produce initial information and thirty working days to produce a complete package, while the expert organisation must complete its causality assessment in only three. Because these stages run in a defined sequence, any delay at the manufacturer’s initial information stage compresses every downstream stage. Companies that have not pre-assembled the data fields for the ten working day submission will find that their first reaction — asking the sales team, the clinical team and the service team to reconstruct batch history — consumes a substantial share of the window.

2. Legal basis

The milestones and the escalation powers are anchored in a compact set of instruments, summarised below with the exact provisions relied upon in this guide.

3. Expert insights

Insight 1: the shortest milestone belongs to the expert organisation, the longest to the manufacturer itself. The expert organisation has only 3 working days to assess causality, while the manufacturer has 30 working days to complete its internal investigation and submit full information. The asymmetry signals where the regulator expects the real bottleneck to be: on the company side. Organisations without a rehearsed plan typically start to distort the record already at the ten working day initial information stage, because they gather facts by email instead of from a structured template.

Insight 2: death and serious harm are not subject to a waiting regime. Under p. 14, where an event results in death, serious harm to health, permanent disability, or constitutes a threat of any of these, RZN may decide on control measures before receiving the manufacturer’s information, and may suspend the use of the device. In practice this means the regulator can act on the report alone. The manufacturer’s fastest possible initial information package is therefore not a formality but the main lever for influencing measures taken while the investigation is still open.

Insight 3: the three response tiers are cut by scope of coverage. Where the report involves two or more models, the entire device is suspended; where two or more batches of the same model are involved, that model is suspended; where a single batch is involved, that batch or series is suspended. This hierarchy defines the boundary of on-site measures. A company that understands the mapping can predict the scope of a field action from the wording of the report, and can target its own investigation at the question that actually decides the scope: how many models and how many batches the evidence touches.

4. Practical recommendations

Working-day clocks punish unprepared organisations disproportionately, so preparation should focus on the two manufacturer milestones.

1. Build a template covering the fields needed for the 10 working day initial information submission, pre-filled with static data such as product, model, batch and quantity in circulation, and store it where the responsible person can access it immediately.
2. For class 3 and class 2b implantable devices, prepare root cause analysis material in advance, so that the internal time consumed before the 30 working day milestone is minimised rather than absorbed by the investigation itself.
3. Rehearse the information transfer plan between the authorised representative and the manufacturer in working days, not calendar days, at least once a year — weekends and public holidays materially change the real deadlines.
4. Log the date of receipt of the RZN notification as the formal start of both manufacturer clocks, and require the responsible person to confirm the two resulting dates in writing on the same day.

5. Verification checklist

Confirm each item below before the procedure enters into force, and update the evidence whenever products, models or batches change.

• □ An adverse event response plan has been established covering both the 10 / 30 working day milestones
• □ The initial information template is pre-filled with static data
• □ The transfer path between the authorised representative and the manufacturer has been tested, measured in working days
• □ The escalation route for immediate reporting of death / serious harm events has been defined
• □ The boundary of on-site measures (entire device / model / batch) is written into the SOP
• □ Receipt of each RZN notification is logged with the two calculated manufacturer deadlines

Regulatory information verified as of 29 October 2026.

GRZAN helps manufacturers and their authorised representatives in Russia build adverse event response plans that hold up under working day deadlines, from initial information templates through full investigation dossiers, and supports the vigilance, recall and inspection readiness work that follows a report to RZN. For support with your Russian post-market compliance programme, contact us at info@grzanglobal.com.